News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Oramed Pharmaceuticals Inc. (ORMP.OB) Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013



6/3/2013 6:36:20 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

JERUSALEM, June 3, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its abstract, titled "Decreased CRP levels in response to a six-week, once-daily oral insulin regimen" has been selected for a poster presentation at the 81st European Atherosclerosis Society (EAS) Congress being held on June 2-5 in Lyon, France.

Help employers find you! Check out all the jobs and post your resume.

Read at PR Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES